We are live on ! Find out more
PASG icon

Passage Bio
PASG

48 hedge funds and large institutions have $21.3M invested in Passage Bio in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.1% less ownership

Funds ownership: 3.05% → 2.95% (-0.1%)

11% less funds holding

Funds holding: 54 → 48 (-6)

32% less capital invested

Capital invested by funds: $31.4M → $21.3M (-$10.1M)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
48
Holders Change
-6
Holders Change %
-11.11%
% of All Funds
0.76%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
14
Reduced
13
Closed
6
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$2K

Top Buyers

1
EAM
Erste Asset Management
Austria
+$164K
2
BCM
Bridgeway Capital Management
Texas
+$96.1K
3
TCM
Tang Capital Management
California
+$82.1K
4
Morgan Stanley
Morgan Stanley
New York
+$54K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$21.3K

Top Sellers

1
LCM
Lynx1 Capital Management
Puerto Rico
-$803K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$102K
3
FLSM
Frazier Life Sciences Management
California
-$75.4K
4
Millennium Management
Millennium Management
New York
-$74.8K
5
AC
Annandale Capital
Texas
-$51K
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
26
Marquette Asset Management
Minnesota
$56.6K – – –
Squarepoint
27
Squarepoint
New York
$48.7K +$3.55K +216 +6%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$40.8K – – –
Northern Trust
29
Northern Trust
Illinois
$34.9K -$4.11K -250 -9%
Goldman Sachs
30
Goldman Sachs
New York
$18.1K -$66 -4 -0.3%
CAM
31
Cresset Asset Management
Illinois
$15.6K – – –
XT
32
XTX Topco
Cayman Islands
$14.1K +$17.6K +1,071 New
HighTower Advisors
33
HighTower Advisors
Illinois
$12K -$15.5K -944 -48%
TRCT
34
Tower Research Capital (TRC)
New York
$9.03K +$9.15K +557 +432%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$8.98K – – –
Barclays
36
Barclays
United Kingdom
$8.65K – – –
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$6.6K -$102K -6,214 -93%
JP Morgan Chase
38
JP Morgan Chase
New York
$6.17K +$6.67K +406 +644%
FDCDDQ
39
Federation des caisses Desjardins du Quebec
Quebec, Canada
$5.27K +$16 +1 +0.3%
TFGT
40
TS Financial Group (TSFG)
Illinois
$1K – – –
SPIA
41
Steward Partners Investment Advisory
New York
$665 – – –
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$515 – – –
Federated Hermes
43
Federated Hermes
Pennsylvania
$336 -$936 -57 -69%
US Bancorp
44
US Bancorp
Minnesota
$329 – – –
Wells Fargo
45
Wells Fargo
California
$190 +$33 +2 +17%
Osaic Holdings
46
Osaic Holdings
Arizona
$182 +$49 +3 +27%
Group One Trading
47
Group One Trading
Illinois
$31 – – –
Qube Research & Technologies (QRT)
48
Qube Research & Technologies (QRT)
United Kingdom
$3 – – –
Bank of America
49
Bank of America
North Carolina
$1 – – –
AC
50
Annandale Capital
Texas
– -$51K -2,717 Closed
1
2
3

PASG Hedge Fund Activity: Q3 2023 in Review

48 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q3 2023, worth a combined $21.3M — down 32% from $31.4M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of PASG and 1 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 14 added.

The largest buyer was Erste Asset Management, adding an estimated $164K. The largest seller was Lynx1 Capital Management, cutting an estimated $803K.

  • 48 institutional investors held Passage Bio (PASG) as of Q3 2023, down from 54 in Q2 2023.
  • Funds reported $21.3M of Passage Bio stock for Q3 2023, down 32% quarter-over-quarter.
  • 1 fund opened new Passage Bio positions in Q3 2023 and 6 closed out, a net change of -5 holders.
  • The largest Passage Bio buyer in Q3 2023 was Erste Asset Management, an estimated $164K added.
  • The largest Passage Bio seller in Q3 2023 was Lynx1 Capital Management, an estimated $803K sold.

Based on aggregated 13F filings for Q3 2023.